Documente Academic
Documente Profesional
Documente Cultură
H .Q. NAME :
Page 1 of 5
POLLACHI
03-01-2013
1
2
3
4
5
6
7
8
9
HIFENAC-P 15 TAB
HIFENAC SR 10 TAB
HIFENAC-D 10 TAB
HIFENAC MR 10 TAB
HIFENAC 10 TAB
HIFENAC GEL 30GM
HIFENAC-TA 10 TAB
HIFENAC-TL 10 TAB
HIFENAC INJECTION 1ML
HIFENAC GRP
17
18
19
20
21
22
23
24
ESPIN-AT 10 TAB
ESPIN-2.5 10 TAB
ESPIN-5 10 TAB
ESPIN-LT 10 TAB
ESPIN-H 10 TAB
ESPIN-1.25 10 TAB
ESPIN MT (10X10 TABLETS)
ESPIN TM (10X10 TABLETS)
ESPIN GRP
25
26
27
28
PANTIUM-40 10 TAB
PANTIUM-D SR 10 CAP
PANTIUM I.V
PANTIUM-L 10 CAP
PANTIUM GRP
Target
(Units)
Sales Achi.
(Units)
(%)
Variance
(+/-)
Target
(Units)
Sales Achi.
(Units)
(%)
Variance
(+/-)
Target
(Units)
Sales
(Units)
Achi.
(%)
Variance
(+/-)
Growth
(%)
YPM
769
507
140
131
356
28
5
0
0
200
150
30
160
90
45
10
10
0
26
30
21
122
25
161
200
0
0
-569
-357
-110
29
-266
17
5
10
0
1726
1386
382
357
973
76
12
0
0
800
280
70
450
160
105
10
20
0
46
20
18
126
16
138
83
0
0
-926
-1106
-312
93
-813
29
-2
20
0
5971
4409
1212
1132
3093
243
39
0
0
2920
1060
280
1320
1120
260
30
50
0
49
24
23
117
36
107
77
0
0
-3051
-3349
-932
188
-1973
17
-9
50
0
-15
-41
37
-4194
-45
20
50
-61
-100
324
118
31
147
124
29
3
6
0
55137
20468
37
-34670
138614
56716
41
-81898
456039
198248
43
-257791
-7
22028
578
18
1
450
0
0
78
0
0
-128
-18
-1
1494
47
3
1950
0
60
131
0
2000
456
-47
57
5379
169
9
4565
40
210
85
24
2333
-814
-129
201
161
-43
0
507
4
23
27960
20922
75
-7038
72314
94605
131
22291
260232
222765
86
-37467
172
24752
27
3
50
0
185
0
23
-3
75
8
60
0
80
0
-15
-8
226
26
160
10
71
38
-66
-16
33
0
18
1
3200
5451
170
2252
8865
6542
74
-2324
26844
18231
68
-8613
31
2026
27
1
10
0
37
0
-17
-1
71
3
70
0
99
0
-1
-3
226
9
180
0
80
0
-46
-9
-35
0
20
0
2075
718
35
-1357
5475
5023
92
-452
17399
13193
76
-4207
-35
1466
242
91
124
1
1
18
1
1
150
45
105
0
0
0
0
0
62
49
85
0
0
0
0
0
-92
-46
-19
-1
-1
-18
-1
-1
662
249
340
3
3
49
3
3
360
150
210
0
0
30
0
0
54
60
62
0
0
61
0
0
-302
-99
-130
-3
-3
-19
-3
-3
2105
794
1076
9
9
153
9
9
1365
600
870
0
0
75
0
0
65
76
81
0
0
49
0
0
-740
-194
-206
-9
-9
-78
-9
-9
-5
17
3
0
0
-17
0
0
152
67
97
0
0
8
0
0
10619
6839
64
-3780
29106
16584
57
-12522
92363
64743
70
-27620
7194
127
40
182
0
0
10
0
0
0
25
0
0
-127
-30
-182
0
347
109
501
0
100
10
0
0
29
9
0
0
-247
-99
-501
0
1104
346
1591
0
1820
63
0
30
165
18
0
0
716
-283
-1591
30
354
-55
-100
0
202
7
0
3
11698
521
-11177
32021
5263
16
-26758
101777
92498
91
-9279
132
10278
Page 2 of 5
POLLACHI
03-01-2013
Target
(Units)
Sales Achi.
(Units)
(%)
Variance
(+/-)
Target
(Units)
Sales Achi.
(Units)
(%)
Variance
(+/-)
Target
(Units)
Sales
(Units)
Achi.
(%)
Variance
(+/-)
Growth
(%)
YPM
172
10
-162
507
120
24
-387
1983
220
11
-1763
24
10353
601
-9752
30516
7208
24
-23308
119356
13215
11
-106142
1468
121042
55520
46
-65522
316911
191940
61
-124971
1074011
622892
58
-451119
40
69210
30 CALINTA 10 TAB
31 CALINTA KIT
17
62
10
0
59
0
-7
-62
47
169
30
10
64
6
-17
-159
146
538
210
262
144
49
64
-276
205
-49
23
29
13317
463
-12854
36328
3434
-32894
115493
63255
55
-52239
-41
7028
11
1
0
0
0
0
-11
-1
29
3
0
0
0
0
-29
-3
91
9
0
0
0
0
-91
-9
-100
0
0
0
3021
-3021
8014
-8014
25094
-25094
-100
7
8
0
0
0
0
0
0
0
-7
-8
0
20
22
0
10
0
0
50
0
0
-10
-22
0
61
68
0
60
30
0
98
44
0
-1
-38
0
200
-25
0
7
3
0
1059
-1059
2948
485
16
-2462
9072
5604
62
-3468
22
623
143
0
0
0
0
0
-143
0
405
0
0
0
0
0
-405
0
1250
0
0
180
0
0
-1250
180
0
0
0
20
6465
-6465
18310
-18310
56513
9420
17
-47093
1047
41
4
12
0
0
0
0
0
0
-41
-4
-12
116
11
34
0
0
0
0
0
0
-116
-11
-34
358
34
102
200
0
0
56
0
0
-158
-34
-102
0
0
0
22
0
0
4513
-4513
12729
-12729
39011
13696
35
-25315
1522
28375
463
-27912
78329
3919
-74410
245183
91975
38
-153208
-25
10219
44
205
71
1
13
20
84
75
0
0
45
41
106
0
0
-24
-121
4
-1
-13
120
558
193
3
36
30
379
306
0
28
25
68
159
0
78
-90
-179
113
-3
-8
379
1773
609
9
118
260
1366
876
0
84
69
77
144
0
71
-119
-407
267
-9
-34
-32
-23
63
0
-7
29
152
97
0
9
10779
5997
56
-4782
29370
23137
79
-6233
93087
83983
90
-9104
-8
9331
358
13
100
40
28
308
-258
27
978
35
130
180
13
514
-848
145
3112
107
290
300
9
280
-2822
193
-34
-40
32
33
14056
4974
35
-9082
38387
9322
24
-29065
122049
18530
15
-103519
-36
2059
CEFTAS O GRP
CALINTA GRP
32 VYFAT 10 CAP
33 VYFAT 60 10 CAP
VYFAT GRP
34 FEBUXOR 40 (10T)
35 FEBUXOR 80 (10T)
36 FEBUXOR 120 (10T)
FEBUXOR GRP
39 INTAP 50, 10 S T
40 INTAP 100, 10 S T
41 INTAP 75, 10 S T
INTAP GRP
ARROWS GROUP
42
43
44
45
46
MOZA GRP
Page 3 of 5
POLLACHI
03-01-2013
49 TOVOK 10 TAB
TOVOK GRP
50 OMETAB-20 10 TAB
OMETAB GRP
51 NUMELIN 75 10 CAP
NUMELIN GRP
52 CEFDITAS-200 6 TAB
CEFDITAS GRP
53 TROMAFRE 10 TAB
TROMAFRE GRP
54 DEFLAZ 1 6 TAB
55 DEFLAZ 30 6 TAB
56 DEFLAZ 6 6 TAB
DEFLAZ GRP
57 HINOCAM 8 10 TAB
HINOCAM GRP
58 VOKMOR 10 CAP
VOKMOR GRP
59 NILOL 10 TAB
NILOL GRP
60 ZOPICON 10 TAB.
ZOPICON GRP
Target
(Units)
Sales Achi.
(Units)
(%)
Variance
(+/-)
Target
(Units)
Sales Achi.
(Units)
(%)
Variance
(+/-)
Target
(Units)
Sales
(Units)
Achi.
(%)
Variance
(+/-)
Growth
(%)
YPM
10
143
20
10
50
-10
61
30
49
-31
612
887
145
275
1748
887
51
-861
5331
2659
50
-2673
295
40
-40
108
25
23
-83
341
75
22
-266
-50
1293
-1293
3492
858
25
-2633
11025
2573
23
-8452
-50
286
-1
-3
-9
161
-161
484
-484
1451
-1451
3
1
1
0
0
0
0
0
0
-3
-1
-1
8
3
3
0
0
0
0
0
0
-8
-3
-3
26
9
9
0
0
0
-26
-9
-9
0
0
0
0
0
0
211
-211
626
-626
1891
-1891
-100
-100
64
18
28
-46
176
54
31
-122
561
252
45
-309
-50
28
1759
505
29
-1254
4838
1516
31
-3322
15421
7049
46
-8371
-50
783
15
-15
41
-41
127
90
71
-37
12
10
700
-700
1913
-1913
5926
4217
71
-1709
12
469
1
19
1
0
0
0
0
0
0
-1
-19
-1
3
50
3
0
21
0
0
42
0
-3
-29
-3
9
158
9
0
105
0
0
66
0
-9
-53
-9
0
-37
0
0
12
0
356
-356
948
367
39
-581
2981
1833
61
-1148
-37
204
-3
10
125
26
10
38
-16
258
-258
689
983
143
294
2238
983
44
-1255
109
0
0
0
0
0
0
0
0
0
0
Page 4 of 5
POLLACHI
03-01-2013
65
66
67
68
FACID 40 14 TAB
FACID 20 14 TAB
FACID AC 14 TAB
FACID INJ 2 ML
Target
(Units)
Sales Achi.
(Units)
(%)
Variance
(+/-)
Target
(Units)
Sales Achi.
(Units)
(%)
Variance
(+/-)
Target
(Units)
Sales
(Units)
Achi.
(%)
Variance
(+/-)
Growth
(%)
YPM
0
0
0
0
0
0
0
0
-9
-9
-9
0
0
0
0
0
0
0
0
0
-61
-9
-178
-139812
-19
13536
1
1
1
0
0
0
0
0
0
0
0
0
-1
-1
-1
0
3
3
3
0
0
0
0
0
0
0
0
0
-3
-3
-3
0
9
9
9
0
-7
20
-20
61
-1
-3
20
-20
59
-59
178
LOMITAS GRP
73 HELIGO KIT.
30212
12363
41
-17848
82573
37070
45
-45503
261639
121827
47
-100
-100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50
0
0
0
0
0
0
0
0
0
50
0
0
0
0
0
0
0
20
60
180
30
50
0
0
0
0
0
20
60
180
30
50
0
0
0
0
0
2
7
20
3
6
3326
3326
18791
18791
2088
50
50
2222
2222
247
50
50
5794
5794
644
50
50
100
100
100
100
11
FACID GRP
69 DOMEL-MT 10 TABLETS
DOMEL GRP
70 SECZOL DS 2 TAB
SECZOL GRP
72 LOMITAS 4 TAB
HELIGO GRP
DAGGERS GROUP
74 BAKFLEX-4 10 CAP
BAKFLEX GRP
75
76
77
78
79
SUPRAPOD GRP
80 CALDIMOR, 15 TAB
CALDIMOR GRP
0
0
0
0
0
0
0
0
0
0
Page 5 of 5
POLLACHI
03-01-2013
83 CLAVITUF-375 6 TABLETS
84 CLAVITUF-625 6 TABLETS
CLAVITUF GRP
OTHERS
Target
(Units)
Sales Achi.
(Units)
(%)
Target
(Units)
Sales Achi.
(Units)
(%)
Variance
(+/-)
Target
(Units)
Sales
(Units)
Achi.
(%)
Variance
(+/-)
Growth
(%)
YPM
0
0
20
60
0
0
20
60
0
0
40
120
0
0
40
120
0
0
40
120
0
0
40
120
0
0
4
13
5468
5468
10936
10936
10936
10936
1215
5468
5468
14262
14262
37743
37743
-475
4194
179628
73814
41
-105814
477813
247191
52
-230622
1580833
874437
55
-706396
23
97160
73814
Variance
(+/-)
0
73814
StockiestSales
73814
0
73814
IMP Notes:
1. All Decimals below 0.5 will be deemed as the lower whole number and above 0.5 as the higher whole number while calculating percentages.
2. Variance is the minimum balance to be achieved to earn full quarters' incentive before deductions like Sales Returns, RGRR and Outstanding Amount if any.
3. In order to arrive at the NET SALES figure for incentive calculation, it is mandatory to deduct (as per incentive circular) outstanding amount & other deduction
including two times salable returns and single time deduction in case goods are recalled from H.O. or cancellation of invoice due to system/human error.
4. In case any query/discripancy noticed, please inform within a week time through your reporting Manager/Executive for checking and taking corrective action.